Skip to main content
Figure 1 | Health and Quality of Life Outcomes

Figure 1

From: A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: Its development and validation

Figure 1

Known groups validity: Comparison of scale scores by known groups. *Statistically significant differences between subjects who were currently on treatment and subjects who were not on treatment (p < 0.01). Statistically significant differences between subjects who indicated that their treatment was extremely to moderately effective and subjects who indicated that their treatment was not effective at all (p < 0.05).

Back to article page